Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin maintenance therapy for frequent-exacerbation COPD
NL-OMON36440Phase 3Active, not recruiting
- Sponsor
- Amphia Ziekenhuis
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Azithromycin maintenance with Placebo (2 arms). Primary endpoint: Reduction in exacerbation number. Started May 2010; status: active, not recruiting.
02
Drugs
azithromycin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NL-OMON36440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36440.